Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and aclidinium bromide

moxifloxacin has been researched along with aclidinium bromide in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(aclidinium bromide)		Trials
(aclidinium bromide)		Recent Studies (post-2010) (aclidinium bromide)
3,1575521,69013946118

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)aclidinium bromide (IC50)
Testosterone 17-beta-dehydrogenase 3Rattus norvegicus (Norway rat)0.0001
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.0001
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.0002
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0002
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0001
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aubets, J; Chuecos, F; Gil, EG; Lasseter, KC1

Trials

1 trial(s) available for moxifloxacin and aclidinium bromide

ArticleYear
Aclidinium bromide, a long-acting antimuscarinic, does not affect QT interval in healthy subjects.
    Journal of clinical pharmacology, 2011, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Muscarinic Antagonists; Quinolines; Tropanes

2011